1.
Br J Dermatol
; 179(3): 787-789, 2018 09.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29624637
Asunto(s)
Adalimumab/uso terapéutico , MicroARNs/sangre , Psoriasis/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Adalimumab/farmacología , Adulto , Anciano , Biomarcadores/sangre , Biomarcadores/metabolismo , Estudios de Casos y Controles , Epigénesis Genética/efectos de los fármacos , Estudios de Factibilidad , Femenino , Voluntarios Sanos , Humanos , Leucocitos Mononucleares/metabolismo , Masculino , MicroARNs/metabolismo , Persona de Mediana Edad , Psoriasis/sangre , Psoriasis/patología , Piel/efectos de los fármacos , Piel/patología , Resultado del Tratamiento , Adulto Joven
2.
J Am Vet Med Assoc
; 200(7): 961-3, 1992 Apr 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-1577651
RESUMEN
Serratia marcescens was the causative agent of bacterial endocarditis in a 2-year-old Arabian stallion. The horse was treated with broad-spectrum antibiotics for 1 month. The horse died several months after treatment was discontinued. To our knowledge, Serratia marcescens has not been reported as the cause of bacterial endocarditis in horses; however, multiple cases of bacterial endocarditis attributable to Serratia marcescens have been documented in human beings. The bacteria is most commonly isolated in immune-compromised patients.